A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Dec 2017
At a glance
- Drugs Vismodegib (Primary)
- Indications Odontogenic cysts
- Focus Adverse reactions; Therapeutic Use
- Acronyms KCOT
- 22 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 19 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 25 Feb 2015 New trial record